[Immunologic indices in patients with sepsis and their changes in response to complex intensive therapy]

Immune status has been studied in the course of intensive care in 48 patients. It has been established that hemosorption may enhance already existing changes in immune homeostasis in patients with sepsis. Therefore, immunostimulating therapy with tactivin and group B vitamins (B1, B6, B12) or ultraviolet (UV) blood irradiation in combination with group B vitamins administration have been included into therapy. Simultaneous use of tactivin, group B vitamins and UV blood irradiation was not advisable due to reduction of immunostimulating effect. Consecutive use of the immunity-stimulating methods seems expedient.